Les Laboratoires Frater-Razes in Consumer Health (Algeria)

September 2016 | 2 pages | ID: L9BBC30D999EN
Euromonitor International Ltd

Abstracts

During 2015, Les Laboratoires Frater-Razes announced three new investments plans: the production of prescription drugs in injectable form; the launch of a new production unit for the manufacture of drugs in dry form with a capacity of 45 million boxes per year; and an increase in the distribution capacity of the company’s subsidiary, Somepharm.

Euromonitor International Local Company Profiles are a concise set of briefings detailing the strategic direction taken by a company. Discover key contact details, the company background and their competitive positioning through this collection of snapshot company profiles.

Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management and Wellbeing.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the Consumer Health market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Contents

Strategic Direction
Key Facts
  Summary 1 Les Laboratoires Frater-Razes: Key Facts
Competitive Positioning
  Summary 2 Les Laboratoires Frater-Razes: Competitive Position 2016